The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from CNW Group

Valeant Pharmaceuticals To Present At 31st Annual J.P. Morgan Healthcare Conference

Wednesday, January 02, 2013

Valeant Pharmaceuticals To Present At 31st Annual J.P. Morgan Healthcare Conference17:01 EST Wednesday, January 02, 2013MONTREAL, Jan. 2, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2013 at 4:30 p.m. PT. The conference will be held at the Westin St. Francis in San Francisco, CA.A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. About ValeantValeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com.(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)Contact Information:Laurie W. Little 949-461-6002 laurie.little@valeant.com SOURCE: Valeant Pharmaceuticals International, Inc.For further information: http://www.valeant.comhttp://photos.prnewswire.com/prnh/20101025/LA87217LOGOPRN Photo Desk, photodesk@prnewswire.com